Inventor · disambiguated record
Peter Van Hoogevest
Also filed as: VAN HOOGEVEST PETER
14 granted patents·11 pending applications·856 citations·filing 1992–2021
93Inventor score
Top patents by PatentIndex Score
25 records- 0198US5466468AParenterally administrable liposome formulation comprising synthetic lipidsCIBA GEIGY CORP·Filed 1994·Granted Nov 14, 1995·526 cites·2 claims
- 0293US5726164ANanosuspensions for intravenous administrationNOVARTIS AG·Filed 1996·Granted Mar 10, 1998·133 cites·11 claims
- 0382US9005597B2Formulation for treatment of vaginal drynessHANSEN KETIL ANDRE·Filed 2009·Granted Apr 14, 2015·16 cites·23 claims
- 0481US5700482AProcess for the preparation of a liposome dispersion under elevated pressure contentsCIBA GEIGY CORP·Filed 1995·Granted Dec 23, 1997·86 cites·14 claims
- 0581US5270053AParenterally administerable liposome formulation comprising synthetic lipidCIBA GEIGY CORP·Filed 1992·Granted Dec 14, 1993·41 cites·2 claims
- 0680US6458770B1Parenteral formulations comprising carbamazepine or its derivativesNOVARTIS AG·Filed 2001·Granted Oct 1, 2002·11 cites·2 claims
- 0778US8889189B2Dissolution composition for examining drug solubilityPHARES PHARM RES NV·Filed 2012·Granted Nov 18, 2014·3 cites·20 claims
- 0872US8632832B2Direct dissolutionLEIGH STEVE·Filed 2007·Granted Jan 21, 2014·3 cites·33 claims
- 0972US7563935B2Crystal forms of astaxanthinPHARES PHARM RES NV·Filed 2008·Granted Jul 21, 2009·2 cites·42 claims
- 1069US6683100B2Organic compoundsNOVARTIS AG·Filed 1999·Granted Jan 27, 2004·33 cites·20 claims
- 1165US2008221065A1Organic compoundsNOVARTIS AG·Filed 2008·Application pending·0 cites
- 1258US8287907B2Dissolution composition for examining drug solubilityLEIGH STEVE·Filed 2006·Granted Oct 16, 2012·1 cites·26 claims
- 1358US2006127423A1Organic compoundsVAN HOOGEVEST PETER·Filed 2006·Application pending·0 cites
- 1458US2016299113A1Dissolution composition for examining drug solubilityPHARES PHARM RES NV·Filed 2014·Application pending·0 cites
- 1555US8753652B2Pharmaceutical composition including a DHA ester to be administered parenterallyLEVERD ELIE·Filed 2010·Granted Jun 17, 2014·1 cites·11 claims
- 1655US2011124691A1Organic CompoundsVAN HOOGEVEST PETER·Filed 2011·Application pending·0 cites
- 1753US2011244028A1Method of solubilizing biologically active compoundsLEIGH STEVE·Filed 2009·Application pending·0 cites
- 1852US12156938B2Liposomes for targeting tumor-associated macrophagesUNIV TWENTE·Filed 2019·Granted Dec 3, 2024·0 cites·9 claims
- 1950US2006286169A1Lipophilic compositionsPHARES PHARM RES NV·Filed 2004·Application pending·0 cites
- 2050US2006153886A1Ambiphilic porous matrixPHARES PHARM RES NV·Filed 2004·Application pending·0 cites
- 2149US2023157309A1Sunflower phospholipid composition containing phosphatidylcholineLIPOID GMBH·Filed 2021·Application pending·0 cites
- 2249US2006233846A1Microdispersion and method of producing samePHARES PHARM RES NV·Filed 2003·Application pending·0 cites
- 2345US10603384B2Pharmaceutical composition containing an antivirally active dihydroquinazoline derivativeAICURIS GMBH & CO KG·Filed 2013·Granted Mar 31, 2020·0 cites·44 claims
- 2440US2006128665A1Marine lipid compositionsPHARES PHARM RES NV·Filed 2003·Application pending·0 cites
- 2539US2015037397A1Pharmaceutical compositions of pyridinium and quinolinium derivativesPALACIOS IZQUIERDO BEATRIZ·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →